Gene · 10544
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetically engineered porcine liver: a new era in transplantation. | Int J Surg | 2026 | 42808109 | PubTator, text mining | PubMed |
| Single-cell multi-omic profiling of heterogeneous PROCR+ cells in mouse mammary gland and its implication for breast cancer. | iScience | 2026 | 42733452 | PubTator, text mining | PubMed |
| PROFET predicts continuous gene expression dynamics from scRNA-seq data to elucidate heterogeneity of cancer treatment responses. | Cell Syst | 2026 | 42664975 | PubTator, text mining | PubMed |
| Visualization of new vessel formation during venous thrombus organization using genetic fate mapping. | Res Pract Thromb Haemost | 2026 | 42656861 | PubTator, text mining | PubMed |
| Comparative Analysis of LPS/IFN-γ and LPS/ATP-Induced Inflammatory Models in BV2 Microglia. | Neurochem Res | 2026 | 42566061 | PubTator, text mining | PubMed |
| Functional definition of endothelial progenitors by PROCR and PDGFRA co-expression. | Angiogenesis | 2026 | 42541597 | PubTator, text mining | PubMed |
| In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway. | Blood Adv | 2026 | 42480122 | PubTator, text mining | PubMed |
| Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma. | Melanoma Res | 2026 | 42440262 | PubTator, text mining | PubMed |
| Endothelial protein C receptor and the endothelial progenitor paradigm: towards a functional definition at last. | Angiogenesis | 2026 | 42377391 | PubTator, text mining | PubMed |
| Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection. | Curr Opin Immunol | 2026 | 42330677 | PubTator, text mining | PubMed |
| Huo-Xue-Xiao-Zhong Decoction prevents thrombus formation of deep vein thrombosis by targeting SOAT2 to modulate the AKT and ERK pathways. | J Ethnopharmacol | 2026 | 42252035 | PubTator, text mining | PubMed |
| CD157+ vascular endothelial stem cells represent a conserved subpopulation with an angiogenic gene expression profile. | Stem Cell Reports | 2026 | 42242216 | PubTator, text mining | PubMed |
| Malaria driven mechanisms shaping cancer risk and aggressiveness in African populations. | Cancer Treat Res Commun | 2026 | 42190523 | PubTator, text mining | PubMed |
| Procr+ endothelial progenitor cells govern hematopoiesis through fine-tuning mesenchymal stem cell niche signals. | Blood | 2026 | 42101967 | PubTator, text mining | PubMed |
| CAR-macrophage therapy: a novel strategy to overcome antimalarial drug resistance by targeting PfEMP1-mediated adhesion. | Malar J | 2026 | 42093036 | PubTator, text mining | PubMed |
| Conditionally Reprogrammed Cells Preserve Cellular Diversity and Permit Genetic Manipulation: Implications for Cancer Heterogeneity and Tissue Regeneration. | Serican J Med | 2026 | 41972234 | PubTator, text mining | PubMed |
| Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis. | Front Immunol | 2026 | 41972171 | PubTator, text mining | PubMed |
| Association Between Genotype and Plasma Levels of EPCR in Type 2 Diabetes Mellitus in Jazan Region, Saudi Arabia: A Case-Control Study. | Int J Gen Med | 2026 | 41909603 | PubTator, text mining | PubMed |
| EPCR in Wound Healing: Mechanisms of Action and Therapeutic Potential. | Cells | 2026 | 41892356 | PubTator, text mining | PubMed |
| γδ T cells at the interface of innate and adaptive immunity in cancer. | J Immunother Cancer | 2026 | 41871873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10544/papers